161 – 170 of 179
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival
(
- Contribution to journal › Article
-
Mark
Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway
(
- Contribution to journal › Article
- 2016
-
Mark
Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis.
(
- Contribution to journal › Article
-
Mark
Cerebral amyloid burden and Alzheimer's disease subtypes - does localization information matter?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography.
(
- Contribution to journal › Article
-
Mark
Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease.
(
- Contribution to journal › Scientific review
-
Mark
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Plasma tau in Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Cognitive and functional changes associated with Aβ pathology and the progression to mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information
(
- Contribution to journal › Article